BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Stanbio Laboratory to Transition HemoPoint® H2 Hemoglobin System to Alere Inc.


4/23/2012 12:12:04 PM

BOERNE, TX, April 20, 2012 – Stanbio Laboratory announced today that the sales, marketing and service functions in the United States for its popular point-of-care HemoPoint® H2 hemoglobin system has been transitioned to Alere, Inc. The transition occurred officially on April 2, 2012. Stanbio Laboratory will maintain sales and marketing responsibilities for the HemoPoint® H2 throughout Mexico, Latin America and South America.

“Stanbio launched the HemoPoint® H2 system in 2004 and it was readily accepted by clinicians in hospitals, physician offices and public health sites across the U.S.,” said Stanbio Laboratory President, William R. Pippin. “We are extremely proud of the reputation we have established for performance accuracy and the high quality of the HemoPoint® H2 system. We are excited now to pass the sales and marketing baton to Alere. We look forward to assisting the highly experienced and much larger sales and marketing team at Alere to drive the HemoPoint® H2 product line as the dominant brand in near-patient hemoglobin testing,” Pippin added.

There will be no change to the core features and functions of the HemoPoint® H2 as a result of this transition. The meter and cuvettes will still be manufactured by EKF diagnostic GmbH, a sister company of Stanbio Laboratory and part of the EKF Diagnostics Group. The color of the HemoPoint® H2 meter will change to coincide with the Alere brand. Distribution partners and end-users alike will continue to have the same reliable HemoPoint® H2 product and disposables they’ve come to expect from Stanbio Laboratory.

Founded in 1960 and headquartered in Boerne, Texas, Stanbio Laboratory manufactures and markets medical testing and diagnostic devices including clinical chemistry, pregnancy, strep A, serology, urinalysis, and point-of-care hemoglobin tests. Stanbio Laboratory’s Quality System is ISO 13485 registered and its facility operates under USFDA current GMP requirements. Stanbio also offers OEM and private labeling capabilities and distributes products in over 125 countries worldwide. This year the company celebrates its 52nd year in business. To find out more about Stanbio, review its news, or learn more about its products, visit www.stanbio.com.

EKF Diagnostics Holdings plc is a worldwide manufacturer of near-patient care equipment for the measurement of glucose, lactate, hemoglobin, hematocrit and glycated hemoglobin (HbA1c). It offers its products to the professional clinical and research laboratories, doctors’ offices, sports clinics, and athletic testing sites. The company is headquartered in London, the United Kingdom.



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES